Key result
BAV increases aortic valve area to ~1.2 cm² as a bridge to noncardiac thoracic surgery.
Why the study?
Balloon aortic valvuloplasty can temporarily relieve left ventricular outflow obstruction in selected patients with severe aortic stenosis requiring time-sensitive noncardiac treatment, such as planned surgery for lung cancer.
Case Report (n=1)
No
Transfemoral balloon aortic valvuloplasty achieved short-term hemodynamic improvement from severe to moderate aortic stenosis as a bridge to reconsidering lung cancer surgery, though complicated by a subtotal femoral artery occlusion that resolved with conservative management.
Answers are grounded in this paper and cite their sources.
May bridge severe aortic stenosis to lung cancer surgery; leaves open safety and role of balloon aortic valvuloplasty.
Introduction: Balloon aortic valvuloplasty (BAV) can temporarily relieve left ventricular outflow obstruction in selected patients with severe aortic stenosis who require time-sensitive noncardiac treatment. We describe its use in preparation for planned surgical treatment of lung cancer. Case presentation: In a 66-year-old man, chest CT revealed a peripheral mass in the left upper lung lobe measuring 30 × 33 × 31 mm and extensive aortic valve calcification. Cytology was consistent with adenocarcinoma, and a multidisciplinary team recommended surgical treatment. Transthoracic echocardiography demonstrated severe aortic stenosis (valve area 0.7 cm²; mean gradient 45 mmHg), prompting postponement of thoracic surgery. Transfemoral BAV was performed using an 18 × 50 mm balloon with rapid ventricular pacing. Follow-up aortography showed no significant aortic regurgitation. Postprocedural echocardiography showed a valve area of 1.2 cm² and a mean gradient of 36 mmHg, interpreted in the report as moderate residual stenosis. Digital subtraction angiography demonstrated subtotal occlusion of the right common femoral artery; following CT angiography and conservative vascular management, no progression of ischemia was observed. On follow-up, the oncologic workup was continued. Conclusion: In this case, BAV achieved short-term hemodynamic improvement and served as an interim step in preparation for reassessing the operability of the lung tumor. The procedure itself carries cardiovascular risks, and the decision regarding thoracic surgery requires renewed multidisciplinary assessment.
No takes yet. Share an insight, caveat, or question.
Hujdur et al. (2026) conducted a case report in Severe aortic stenosis and lung adenocarcinoma (n=1). Transfemoral balloon aortic valvuloplasty (BAV) vs. Baseline pre-procedural status was evaluated on Aortic valve area (cm²). Transfemoral balloon aortic valvuloplasty increased aortic valve area from 0.7 to 1.2 cm² and reduced mean gradient from 45 to 36 mmHg in a patient with lung adenocarcinoma.
Synapse has enriched 10 related papers. Consider them for comparative context: